ImmunityBio Inc - Common Stock — キャッシュフロー (NASDAQ:IBRX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -70.45 M-274.42 M-337.51 M-366.76 M-391.24 M-304.94 M -304.94 M 投資活動によるキャッシュフロー -20.59 M-84.89 M27.3 M-30.47 M-12.25 M-149.8 M -149.8 M 財務活動によるキャッシュフロー 86.97 M505.44 M233.61 M558.34 M281.63 M400.24 M 400.24 M フリーキャッシュフロー -73.09 M-307.98 M-436.9 M-397.34 M-398.12 M-309.19 M -308.78 M

ニュース

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

Why Is ImmunityBio Stock Rallying Thursday? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold (NASDAQ:IBRX)

ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?

ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims

“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26% - TipRanks.com

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

ImmunityBio Crashes On FDA Warning Over Anktiva Claims - ImmunityBio (NASDAQ:IBRX)

Can Anktiva's Label Expansion Unlock the Next Growth Phase for IBRX?

ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion